HighTide Therapeutics, Inc. (HKG:2511)
3.210
-0.110 (-3.31%)
May 28, 2026, 3:59 PM HKT
21.13% (1Y)
| Market Cap | 1.83B +37.0% |
| Revenue (ttm) | n/a |
| Net Income | -272.60M |
| EPS | -0.57 |
| Shares Out | 571.33M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 634,500 |
| Open | 3.300 |
| Previous Close | 3.320 |
| Day's Range | 3.150 - 3.310 |
| 52-Week Range | 1.800 - 4.720 |
| Beta | -0.23 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 27, 2026 |